Josephine van Dongen

Chapter 4 108 References 1. Kotloff KL.The Burden and Etiology of Diarrheal Illness in Developing Countries. Pediatr Clin North Am . 2017;64(4):799-814. doi:10.1016/j.pcl.2017.03.006 2. Burnett E, Jonesteller CL,Tate JE,Yen C, Parashar UD. Global Impact of Rotavi- rus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea. J Infect Dis . 2017;215(11):1666-1672. 3. International Vaccine Access Center. Current Rotavirus Vaccine Intro status. Bloom Sch Public Heal. 2018;([cited 2019]). https://view-hub.org/map/?set=current-vaccine-in- tro-status&category=rv&group=vaccine-introduction 4. Burnett E, Parashar UD,Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Heal. 2020;8(9):e1195-e1202. doi:10.1016/S2214-109X(20)30262-X 5. Soares-Weiser K, Maclehose H, Bergman H, et al.Vaccines for preventing rotavirus diarrhoea: vaccines in use (Review). Cochrane Rev . Published online 2012. http://www.the - cochranelibrary.com 6. Hungerford D, Smith K,Tucker A, et al. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis . 2017;17. doi:10.1186/s12879-017-2613-4 7. Chiappini E, Petrolini C, Sandini E, et al. Update on vaccination of preterm infants: a systematic review about safety and efficacy/effectiveness. Proposal for a position statement by Italian Society of Pediatric Allergology and Immunology jointly with the Italian Society of Neonatology. Expert Rev Vaccines . 2019;18(5):523-545. doi:10.1080/14760584.2019.1604230 8. Rouers EDM, Bruijning-Verhagen PCJ, van Gageldonk PGM, van Dongen JAP, Sanders EAM, Berbers GAM. Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants. Jama . 2020;324(11):1068-1077. doi:10.1001/jama.2020.12316 9. Bonhoeffer J, Siegrist CA, Heath PT. Immunisation of premature infants. Arch Dis Child . 2006;91(11):929-935. doi:10.1136/adc.2005.086306 10.Bruijning-Verhagen P, Mangen M-JJ, Felderhof M, et al.Targeted rotavirus vaccination of high- risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med . 2013;11(112). doi:10.1186/1741-7015-11-112 11. Bruijning-Verhagen PCJ. RIVAR study protocol. Published 2014. Accessed November 17, 2020. https://www.trialregister.nl/trial/5213 12. Ruuska T,Vesikari T. Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes. Scand J Infect Dis . 1990;22(3):259-267. doi:10.3109/00365549009027046 13. Schnadower D,Tarr PI, Gorelick MH, et al.Validation of the modified vesikari score in children with gastroenteritis in 5 US emergency departments. J Pediatr Gastroenterol Nutr . 2013;57(4):514-519. doi:10.1097/MPG.0b013e31829ae5a3 14. Freedman SB, Eltorky M, Gorelick M. Evaluation of a Gastroenteritis Severity Score for Use in Outpatient Settings. Pediatrics . 2010;125(6):e1278-e1285. doi:10.1542/peds.2009- 3270 15. Wilhelmi I, Roman E, Sánchez-Fauquier A.Viruses causing gastroenteritis. Clin Micro- biol Infect . 2003;9(4):247-262. doi:10.1046/j.1469-0691.2003.00560.x 16. Xie J, Nettel-Aguirre A, Lee BE, et al. Relationship between enteric pathogens and acute gastroenteritis disease severity: a prospective cohor t study. Clin Microbiol Infect. 2019;25(4):454-461. doi:10.1016/j.cmi.2018.06.016 17. NederlandseWerkgroep voor Klinische Virologie.Virologische weekstaten. Accessed in Feb 2020. https://www.rivm.nl/virologische-weekstaten/recente-virologie-uitslagen 18. World population by Country 2020. Accessed September 11, 2020. https://world- populationreview.com/continents/capitals/europe 19. Knol MJ, Le Cessie S, Algra A,Vandenbroucke JP, Groenwold RHH. Overestimation of risk ratios by odds ratios in trials and cohor t studies: Alternatives to logistic regression. CMAJ . Published online 2012. doi:10.1503/cmaj.101715 20. Rosettie KL,Vos T, Mokdad AH, et al. Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis. Am J Trop

RkJQdWJsaXNoZXIy ODAyMDc0